Peter Vervaeke

Sulfated Escherichia coli K5 Polysaccharide Derivatives Inhibit Dengue Virus Infection of Human Microvascular Endothelial Cells by Interacting with the Viral Envelope Protein E Domain III

Peter Vervaeke, Marijke Alen, Sam Noppen et al. · PLoS ONE · 2013 · 40 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +16

Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus

Vincent Vanheule, Peter Vervaeke, Anneleen Mortier et al. · Biochemical Pharmacology · 2015 · 35 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +16

<i>Mycoplasma hyorhinis</i>‐encoded cytidine deaminase efficiently inactivates cytosine‐based anticancer drugs

Johan Vande Voorde, Peter Vervaeke, Sandra Liekens et al. · FEBS Open Bio · 2015 · 27 citations · Full text

Medicine, Oncology, Pharmacology +13

Different positions of amide side chains on the benzimidazo[1,2-<i>a</i>]quinoline skeleton strongly influence biological activity

Nataša Perin, Jasna Alić, Sandra Liekens et al. · New Journal of Chemistry · 2018 · 27 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

A Novel Series of Indole Alkaloid Derivatives Inhibit Dengue and Zika Virus Infection by Interference with the Viral Replication Complex

Antonios Fikatas, Peter Vervaeke, Eef Meyen et al. · Antimicrobial Agents and Chemotherapy · 2021 · 22 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17